A61P 5 - Drugs for disorders of the endocrine system

Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908)
11/2011
11/03/2011	WO2011136264A1 [5,6] heterocyclic compound
11/03/2011	US20110269797 Anln protein as an endocrine treatment predictive factor
11/03/2011	US20110269788 Spiro-oxindole-derivatives as sodium channel blockers
11/03/2011	US20110269725 Novel estrogenic compounds
11/03/2011	US20110269700 Glucoside derivatives and uses thereof
11/03/2011	US20110268970 Mesoporous nanoparticles
11/03/2011	US20110268806 Antisolvent solidification process
11/03/2011	US20110268727 Anti-interferon-alpha antibodies
11/03/2011	US20110268724 Methods and materials relating to cd84-like polypeptides and polynucleotides
11/03/2011	US20110268719 Annatto Extract Compositions, Including Geranyl Geraniols And Methods Of Use
11/03/2011	CA2793715A1 Peptide for improving in vivo stability of physiologically active substance or the like and physiologically active substance with improved in vivo stability
11/03/2011	CA2791020A1 [5,6] heterocyclic compound
11/02/2011	EP2381946A1 Methods for treating vasomotor symptoms in castrated prostatic cancer patients with low dose cyproterone acetate
11/02/2011	CN102231977A Delivery of dry formulations of octreotide
11/02/2011	CN102231976A Octreotide implant having a release agent
11/02/2011	CN102229668A GLP-1 (glucagon-like peptide-1) derivative and application thereof
11/02/2011	CN102228644A Medicament for treating thyrocele and preparation method thereof
11/02/2011	CN102228506A Composition of malaytea scurfpea extract as well as preparation method and use thereof
11/02/2011	CN102228454A Brain targeting via olfactory pathway fragrant essential oil compound and monomer pharmaceutical composition with functions for preventing and treating brain atrophy and activating brain cells
11/01/2011	US8048918 Treatment of hyperproliferative diseases
11/01/2011	US8048873 Synergistic pharmaceutical combination for the prevention or treatment of diabetes
11/01/2011	US8048869 Estrogenic component comprising estetrol and estetrol-like substances, which has relatively low estrogenic potency, metabolic stability, long half-life; triene steroids; osteoporosis, arteriosclerosis, cognitive disturbances, Alzheimer's disease, peri- or post-menopausal disorders
11/01/2011	CA2531911C Specific glucocorticosteroid having an anti-inflammatory activity
11/01/2011	CA2507766C Novel dry powder inhalation system for transpulmonary administration
11/01/2011	CA2176942C Bmp-12, bmp-13 and tendon-inducing compositions thereof
10/2011
10/27/2011	WO2011133224A1 Organic compounds
10/27/2011	WO2011131596A1 Heteroaryl-cyclohexyl-tetraazabenzo[e]azulenes as vasopressin v1a receptor antagonists
10/27/2011	WO2011131026A1 Furo[3, 2-g]chromene compounds and uses thereof
10/27/2011	WO2011130877A1 Crystalline form of methylprednisolone aceponate monohydrate and preparation methods thereof
10/27/2011	WO2011098437A3 Progesterone receptor antagonists
10/27/2011	US20110263721 Aryl di-substituted propenone compounds
10/27/2011	US20110263703 Solid forms of selective androgen receptor modulators
10/27/2011	US20110263589 Method for preventing or treating a glucocorticoid receptor-related disease
10/27/2011	US20110263582 Cyclic urea inhibitors of 11 b-hydroxysteroid dehydrogenase 1
10/27/2011	US20110263564 Pyridine, bicyclic pyridine and related analogs as sirtuin modulators
10/27/2011	US20110263547 C-19 steroids for specific therapeutic uses
10/27/2011	US20110263544 1-Phenylpyrrole Derivatives
10/27/2011	US20110263504 Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage
10/27/2011	US20110263501 Growth Hormone Conjugate with Increased Stability
10/27/2011	US20110263027 Adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby
10/27/2011	US20110262419 Specifically targeted catalytic antagonists and uses thereof
10/27/2011	US20110262410 Use of live bacteria for growth promotion in animals
10/27/2011	US20110262388 Novel inhibitors
10/27/2011	CA2795526A1 Heteroaryl-cyclohexyl-tetraazabenzo[e]azulenes as vasopressin v1a receptor antagonists
10/26/2011	EP2380898A1 Process to make glucocortisoid compounds
10/26/2011	EP2380877A1 Pyridine-3-carboxyamide derivative
10/26/2011	EP2380850A1 Modified sodium-montmorillonite, preparing method and uses thereof
10/26/2011	EP2380592A2 Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
10/26/2011	EP2379529A1 Novel compounds
10/26/2011	EP2379100A1 Method for treating hyperglycemia with glp-1
10/26/2011	EP2379099A1 Method for the prophylaxis or treatment of flushing
10/26/2011	EP2066636B1 5-phenyl-nicotinamide derivatives
10/26/2011	CN102227428A Arylcyclohexylethers of dihydrotetraazabenzoazulenes for use as vasopressin via receptor antagonists
10/26/2011	CN102227420A Quinazolinone, quinolone and related analogs as sirtuin modulators
10/26/2011	CN102227409A Pyridine-3-carboxyamide derivative
10/26/2011	CN102225152A Preparation method of Maiwei rehmannia oral preparation
10/26/2011	CN102225047A Enteric solid oral dosage form of bisphosphonate containing a chelating agent
10/25/2011	US8044182 Adiponectin and uses thereof
10/25/2011	US8044025 Urocortin proteins and uses thereof
10/25/2011	CA2536487C Rapid dissolution formulation of a calcium receptor-active compound
10/25/2011	CA2505538C Papaya puree and its use
10/25/2011	CA2366277C Grb7 family proteins and the insulin receptor for screening new medications
10/20/2011	WO2011129424A1 Pharmaceutical agent for prevention and/or treatment of htlv-1-associated myelopathy
10/20/2011	WO2011127625A1 Method for regulating microrna content in organisms and uses thereof
10/20/2011	WO2011098436A3 Progesterone receptor antagonists
10/20/2011	WO2011092293A3 Cyclohexyl amide derivatives as crf receptor antagonists
10/20/2011	US20110257210 Benzimidazole derivatives and their use for modulating the gabaa receptor complex
10/20/2011	US20110257098 Compositions and methods for treating growth hormone deficiency
10/20/2011	US20110257097 Pharmaceutical compositions of somatotrophic hormones
10/20/2011	US20110256134 Methods of treatment using anti-oxidized ldl antibodies
10/20/2011	US20110256097 Treatment of Conditions that Increase in Severity and/or Occurrence During One or More Phases of the Menstrual Cycle
10/20/2011	US20110256070 Pharmaceutical compositions and methods for administering the same
10/20/2011	CA2796336A1 Methods for treating glucose metabolic disorders
10/19/2011	EP2376502A1 Thiazolopyridine sirtuin modulating compounds
10/19/2011	EP1499321B1 Methods for increasing the therapeutic response to electroconvulsive therapy ("ect")
10/19/2011	EP1372735B1 Conjugate of hydroxyalkyl starch and an active agent
10/19/2011	EP1282615B1 Chroman derivatives as estrogenic compounds
10/19/2011	CN102223884A Solid pharmaceutical composition
10/19/2011	CN101268073B Heterocyclic compound, and production process and use thereof
10/18/2011	CA2478813C Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors
10/18/2011	CA2466906C Pharmaceutical composition comprising a prostaglandin e1
10/18/2011	CA2419842C New aporphine esters and their use in therapy
10/18/2011	CA2398018C Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
10/13/2011	WO2011127232A2 Substituted androst-4-ene diones
10/13/2011	WO2011089250A3 Stable growth hormone compounds
10/13/2011	WO2011088160A3 Novel cyp17 inhibitors
10/13/2011	US20110251185 Benzoxazines and related nitrogen-containing heterobicyclic compounds useful as mineralocorticoid receptor modulating agents
10/13/2011	US20110251167 Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same
10/13/2011	US20110251145 Phytoestrogenic Compositions for Preventing or Treating Symptoms Associated with Menopause
10/13/2011	US20110251124 Regulation of mineral and skeletal metabolism
10/13/2011	US20110250299 Organogel compositions and processes for producing
10/13/2011	US20110250274 Estriol formulations
10/13/2011	US20110250261 Circular dumbbell decoy oligodeoxynucleotides (cdodn) containing dna bindings sites of transcription
10/13/2011	CA2794565A1 Substituted androst-4-ene diones
10/12/2011	EP2374794A1 Cyclic amine compounds
10/12/2011	EP2374788A1 Indanyl compounds
10/12/2011	CN102210873A Application of C10orf116 genes in preparing medicament for improving insulin sensitivity of adipose tissue
10/12/2011	CN102210865A Concomitant pharmaceutical agents and use thereof
10/12/2011	CN102210696A Pharmaceutical composition containing zoledronic acid
10/12/2011	CN102210666A Medical use of salvianolic acid A

1 ... 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 ... 290